Cognetivity Neurosciences Ltd.
CGN
CNSX
10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | |
---|---|---|---|---|---|
Net Income | -6.41M | -6.26M | -6.04M | -5.66M | -7.85M |
Total Depreciation and Amortization | 19.50K | 19.30K | 18.90K | 18.90K | 21.40K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 3.98M | 2.99M | 2.10M | 939.90K | 862.90K |
Change in Net Operating Assets | -448.50K | 211.30K | 1.12M | 101.70K | 3.04M |
Cash from Operations | -2.86M | -3.04M | -2.80M | -4.60M | -3.93M |
Capital Expenditure | -100.00 | 800.00 | -3.80K | -18.50K | -39.00K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -17.80K | -14.20K | -22.50K | -36.00K | 122.30K |
Cash from Investing | -17.90K | -13.40K | -26.30K | -54.50K | 83.40K |
Total Debt Issued | -152.90K | -150.60K | 0.00 | 0.00 | 504.60K |
Total Debt Repaid | -12.10K | -300.00 | 11.30K | 0.00 | -10.80K |
Issuance of Common Stock | -- | 0.00 | 0.00 | 2.65M | 4.11M |
Repurchase of Common Stock | -13.40K | -13.40K | -13.40K | -13.40K | -- |
Issuance of Preferred Stock | -- | 4.30M | 4.30M | 4.30M | 4.30M |
Repurchase of Preferred Stock | -50.40K | -50.40K | -50.40K | -50.40K | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -169.80K | 3.07M | 3.19M | 5.27M | 6.86M |
Foreign Exchange rate Adjustments | 1.50K | 1.10K | 6.20K | -200.00 | -500.00 |
Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | -- | -- | -- |
Net Change in Cash | -3.05M | 15.50K | 370.60K | 621.90K | 3.02M |